(Q48367061)

English

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

scientific article published in October 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

Geoffrey A. Donnan

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

13

object named as

P Trouillas

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

author name string

W Hacke

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

C Fieschi

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

R von Kummer

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

A Davalos

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

D Meier

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

V Larrue

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

E Bluhmki

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

S Davis

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

D Schneider

11

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

E Diez-Tejedor

12

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

352

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

9136

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

1245-1251

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolytic therapy with streptokinase in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemorrhagic cerebral infarction--a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemorrhagic transformation in cerebral embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke St

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolving stroke and the ischemic penumbra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908020-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)08020-9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9788453

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48367061&oldid=2195967487"